Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-ones for Pharmaceuticals.
Burgart YV, Elkina NA, Shchegolkov EV, Krasnykh OP, Makhaeva GF, Triandafilova GA, Solodnikov SY, Boltneva NP, Rudakova EV, Kovaleva NV, Serebryakova OG, Ulitko MV, Borisevich SS, Gerasimova NA, Evstigneeva NP, Kozlov SA, Korolkova YV, Minin AS, Belousova AV, Mozhaitsev ES, Klabukov AM, Saloutin VI. Burgart YV, et al. Among authors: elkina na. Molecules. 2022 Dec 21;28(1):59. doi: 10.3390/molecules28010059. Molecules. 2022. PMID: 36615256 Free PMC article.
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
Khudina OG, Makhaeva GF, Elkina NA, Boltneva NP, Serebryakova OG, Shchegolkov EV, Rudakova EV, Lushchekina SV, Burgart YV, Bachurin SO, Richardson RJ, Saloutin VI. Khudina OG, et al. Among authors: elkina na. Bioorg Med Chem Lett. 2019 Dec 1;29(23):126716. doi: 10.1016/j.bmcl.2019.126716. Epub 2019 Oct 14. Bioorg Med Chem Lett. 2019. PMID: 31640885
Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.
Makhaeva GF, Elkina NA, Shchegolkov EV, Boltneva NP, Lushchekina SV, Serebryakova OG, Rudakova EV, Kovaleva NV, Radchenko EV, Palyulin VA, Burgart YV, Saloutin VI, Bachurin SO, Richardson RJ. Makhaeva GF, et al. Among authors: elkina na. Bioorg Chem. 2019 Oct;91:103097. doi: 10.1016/j.bioorg.2019.103097. Epub 2019 Jul 3. Bioorg Chem. 2019. PMID: 31323527
Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Kovaleva NV, Rudakova EV, Elkina NA, Shchegolkov EV, Burgart YV, Stupina TS, Terentiev AA, Radchenko EV, Palyulin VA, Saloutin VI, Bachurin SO, Richardson RJ. Makhaeva GF, et al. Among authors: elkina na. Eur J Med Chem. 2021 Jun 5;218:113385. doi: 10.1016/j.ejmech.2021.113385. Epub 2021 Mar 15. Eur J Med Chem. 2021. PMID: 33831780
New Multifunctional Agents for Potential Alzheimer's Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones.
Elkina NA, Grishchenko MV, Shchegolkov EV, Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Astakhova TY, Radchenko EV, Palyulin VA, Zhilina EF, Perminova AN, Lapshin LS, Burgart YV, Saloutin VI, Richardson RJ. Elkina NA, et al. Biomolecules. 2022 Oct 24;12(11):1551. doi: 10.3390/biom12111551. Biomolecules. 2022. PMID: 36358901 Free PMC article.